CCL5 and cancer: Karnoub et al. proved that bone-marrow-derived human mesenchymal stem cells could cause the breast cancer cells to increase their metastatic potency, and CCL5 secreted by MSCs acts in a paracrine fashion on the cancer cells to enhance their motility, invasion and metastasis [13].